Literature DB >> 19435821

GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma.

Ty W Abel1, Cara Clark, Brian Bierie, Anna Chytil, Mary Aakre, Agnieszka Gorska, Harold L Moses.   

Abstract

A subset of neoplastic cells within human high-grade gliomas has features associated with stem cells. These cells may sustain glioma growth, and their stem-like properties may confer resistance to standard glioma treatments. Whether glioma stem cells derive from indigenous neural stem cells (NSC), or from tumor cells that have reacquired stem cell-like properties, is unknown. However, signaling pathways that are tightly regulated and central to NSC biology, including the Ras/Raf/Erk pathway, are hyperactive and pathogenic in gliomagenesis. Furthermore, data in animal models suggests that, in some cases, tumors are initiated in the subventricular zone (SVZ), a stem/progenitor cell niche in the mature brain. We activated oncogenic K-ras in mouse glioneuronal precursor cells and adult SVZ cells using GFAP-Cre. GFAP-Cre+/K-ras(G12D) mice showed a marked expansion of glial fibriallary acidic protein (GFAP)- and TUJ1-expressing cell populations in the SVZ. In addition, mice developed intermediate grade, infiltrating glioma with 100% penetrance. Tumors were consistently located in the amygdalohippocampal region and nearby cortex, often in association with the lateral ventricle and expanded SVZ. Tumor cells expressed markers associated with neural progenitor cells, including Olig2, Bmi-1, and PDGFR-alpha. These data suggest that infiltrating tumor cells may arise from NSC transformed by activation of oncogenic K-ras in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435821      PMCID: PMC3406747          DOI: 10.1158/1541-7786.MCR-08-0477

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  45 in total

1.  Conditional inactivation of the TGF-beta type II receptor using Cre:Lox.

Authors:  Anna Chytil; Mark A Magnuson; Christopher V E Wright; Harold L Moses
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

2.  EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells.

Authors:  Fiona Doetsch; Leopoldo Petreanu; Isabelle Caille; Jose Manuel Garcia-Verdugo; Arturo Alvarez-Buylla
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

3.  hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.

Authors:  L Zhuo; M Theis; I Alvarez-Maya; M Brenner; K Willecke; A Messing
Journal:  Genesis       Date:  2001-10       Impact factor: 2.487

4.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

Review 5.  Mammalian neural stem cells.

Authors:  F H Gage
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

6.  Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.

Authors:  Tatyana N Ignatova; Valery G Kukekov; Eric D Laywell; Oleg N Suslov; Frank D Vrionis; Dennis A Steindler
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

Review 7.  Glioma stem cells: a midterm exam.

Authors:  Charles D Stiles; David H Rowitch
Journal:  Neuron       Date:  2008-06-26       Impact factor: 17.173

8.  Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.

Authors:  Lene Uhrbom; Chengkai Dai; Joseph C Celestino; Marc K Rosenblum; Gregory N Fuller; Eric C Holland
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

9.  Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.

Authors:  Robert M Bachoo; Elizabeth A Maher; Keith L Ligon; Norman E Sharpless; Suzanne S Chan; Mingjian James You; Yi Tang; Jessica DeFrances; Elizabeth Stover; Ralph Weissleder; David H Rowitch; David N Louis; Ronald A DePinho
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

Review 10.  The molecular and genetic basis of neurological tumours.

Authors:  Yuan Zhu; Luis F Parada
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  28 in total

1.  Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma.

Authors:  Laura D Hover; Philip Owens; Alexander L Munden; Jialiang Wang; Lola B Chambless; Corey R Hopkins; Charles C Hong; Harold L Moses; Ty W Abel
Journal:  Neuro Oncol       Date:  2015-12-18       Impact factor: 12.300

2.  Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression.

Authors:  Christopher J Pirozzi; Austin B Carpenter; Matthew S Waitkus; Catherine Y Wang; Huishan Zhu; Landon J Hansen; Lee H Chen; Paula K Greer; Jie Feng; Yu Wang; Cheryl B Bock; Ping Fan; Ivan Spasojevic; Roger E McLendon; Darell D Bigner; Yiping He; Hai Yan
Journal:  Mol Cancer Res       Date:  2017-02-01       Impact factor: 5.852

3.  Oncogenic Kras expression in postmitotic neurons leads to S100A8-S100A9 protein overexpression and gliosis.

Authors:  Myung-Jeom Ryu; Yangang Liu; Xiaofen Zhong; Juan Du; Nicholas Peterson; Guangyao Kong; Hongda Li; Jinyong Wang; Shahriar Salamat; Qiang Chang; Jing Zhang
Journal:  J Biol Chem       Date:  2012-05-10       Impact factor: 5.157

Review 4.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

5.  Oncogenic KRAS promotes malignant brain tumors in zebrafish.

Authors:  Bensheng Ju; Wenbiao Chen; Brent A Orr; Jan M Spitsbergen; Sujuan Jia; Christopher J Eden; Hannah E Henson; Michael R Taylor
Journal:  Mol Cancer       Date:  2015-02-03       Impact factor: 27.401

6.  Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall.

Authors:  Shengwen Calvin Li; Long T Vu; Hector W Ho; Hong Zhen Yin; Vic Keschrumrus; Qiang Lu; Jun Wang; Heying Zhang; Zhiwei Ma; Alexander Stover; John H Weiss; Philip H Schwartz; William G Loudon
Journal:  Cancer Cell Int       Date:  2012-09-20       Impact factor: 5.722

7.  Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma.

Authors:  Sabah O Ghazi; Michelle Stark; Zhiguo Zhao; Bret C Mobley; Alex Munden; Laura Hover; Ty William Abel
Journal:  J Neuropathol Exp Neurol       Date:  2012-08       Impact factor: 3.685

8.  Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN.

Authors:  Xi-Rui Wang; Hui Luo; Hai-Lin Li; Lei Cao; Xie-Feng Wang; Wei Yan; Ying-Yi Wang; Jun-Xia Zhang; Tao Jiang; Chun-Sheng Kang; Ning Liu; Yong-Ping You
Journal:  Neuro Oncol       Date:  2013-10-03       Impact factor: 12.300

Review 9.  The bright and the dark sides of DNA repair in stem cells.

Authors:  Guido Frosina
Journal:  J Biomed Biotechnol       Date:  2010-04-08

10.  NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.

Authors:  A C Solga; S M Gianino; D H Gutmann
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.